Get the Stockscreener App
113.48
0.38%
-0.43
After Hours:
113.48
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Abbott Laboratories stock is traded at $113.48, with a volume of 6.17M.
It is down -0.38% in the last 24 hours and up +0.17% over the past month.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
See More
Previous Close:
$113.91
Open:
$113.62
24h Volume:
6.17M
Relative Volume:
1.34
Market Cap:
$196.83B
Revenue:
$41.22B
Net Income/Loss:
$5.77B
P/E Ratio:
34.49
EPS:
3.29
Net Cash Flow:
$6.49B
1W Performance:
+1.04%
1M Performance:
+0.17%
6M Performance:
+8.41%
1Y Performance:
-0.39%
1-Day Range:
$113.39
$114.79
1-Week Range:
$110.86
$114.79
52-Week Range:
$99.71
$121.64
Abbott Laboratories Stock (ABT) Company Profile
Name
Abbott Laboratories
Sector
Industry
Phone
(224) 667-6100
Address
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Compare ABT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABT
Abbott Laboratories
|
113.48 | 196.83B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
383.42 | 146.17B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
98.66 | 145.41B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.08 | 112.94B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.78 | 41.16B | 6.60B | 4.16B | 490.10M | 6.93 |
Abbott Laboratories Stock (ABT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-08-24 | Initiated | Oppenheimer | Outperform |
| Sep-19-24 | Initiated | Piper Sandler | Overweight |
| Jul-30-24 | Downgrade | Edward Jones | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-21-23 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| May-30-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-20-23 | Reiterated | Barclays | Overweight |
| Apr-20-23 | Reiterated | Bernstein | Outperform |
| Apr-20-23 | Reiterated | JP Morgan | Overweight |
| Apr-20-23 | Reiterated | Raymond James | Outperform |
| Apr-20-23 | Reiterated | UBS | Buy |
| Apr-20-23 | Reiterated | Wolfe Research | Underperform |
| Mar-29-23 | Initiated | UBS | Buy |
| Oct-26-22 | Initiated | Mizuho | Neutral |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-06-22 | Initiated | Wolfe Research | Underperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-27-22 | Reiterated | Credit Suisse | Outperform |
| Jan-27-22 | Reiterated | Morgan Stanley | Overweight |
| Jan-27-22 | Reiterated | Raymond James | Outperform |
| Jan-27-22 | Reiterated | UBS | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-27-21 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-14-21 | Initiated | Redburn | Neutral |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Neutral |
| Jan-28-21 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Jun-01-20 | Downgrade | Goldman | Neutral → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Neutral |
| Jan-02-20 | Downgrade | Guggenheim | Buy → Neutral |
| Jun-13-19 | Reiterated | BofA/Merrill | Buy |
| Feb-07-19 | Reiterated | BofA/Merrill | Buy |
| Jan-02-19 | Downgrade | Citigroup | Neutral → Sell |
| Nov-30-18 | Upgrade | Goldman | Neutral → Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Jan-30-18 | Reiterated | Citigroup | Neutral |
| Jan-25-18 | Reiterated | Stifel | Buy |
| Jan-25-18 | Upgrade | William Blair | Mkt Perform → Outperform |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Jan-02-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Jan-02-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-19-17 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-19-17 | Reiterated | Stifel | Buy |
View All
Abbott Laboratories Stock (ABT) Latest News
Abbott Stock Ahead of Q4 Earnings Results: Smart Buy or Risky Move? - Nasdaq
MassMutual Private Wealth & Trust FSB Decreases Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Top 10 Medical Device Predictions for 2025 - GlobeNewswire Inc.
Annex Advisory Services LLC Purchases 3,177 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Arkadios Wealth Advisors Sells 3,749 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Carotid Stent Market Overall Study Report 2025-2032 | Abbott Laboratories, B. Braun SE, Biotronik SE & Co KG - openPR
Abbott Laboratories (NYSE:ABT) Shares Purchased by Financial & Tax Architects LLC - MarketBeat
HB Wealth Management LLC Purchases 14,259 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Verity & Verity LLC Increases Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Lummis Asset Management LP Lowers Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Integrated Investment Consultants LLC Acquires 11,475 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Folger Nolan Fleming Douglas Capital Management Inc. Sells 3,851 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Holdings Lifted by Brooklyn Investment Group - MarketBeat
Aaron Wealth Advisors LLC Has $1.47 Million Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Looking to the Future: Why Abbott Laboratories is a Must-Watch Stock - Jomfruland.net
Jim Cramer on Abbott Laboratories (ABT): ‘I Think Abbott Will Win These Baby Formula Cases’ - Insider Monkey
5,660 Shares in Abbott Laboratories (NYSE:ABT) Bought by Sax Wealth Advisors LLC - MarketBeat
Merit Financial Group LLC Buys 7,316 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Hennion & Walsh Asset Management Inc. Has $1.45 Million Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Trust Co. of Vermont Sells 9,600 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Cardiac Biomarker Industry Market is Booming Worldwide | Abbott Laboratories, Roche Diagnostics - openPR
Relyea Zuckerberg Hanson LLC Purchases 14,960 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Householder Group Estate & Retirement Specialist LLC - MarketBeat
Avanza Fonder AB Invests $20.64 Million in Abbott Laboratories (NYSE:ABT) - MarketBeat
Tompkins Financial Corp Buys 2,410 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Chemistry Wealth Management LLC Makes New $267,000 Investment in Abbott Laboratories (NYSE:ABT) - MarketBeat
Declining Stock and Decent Financials: Is The Market Wrong About Abbott Laboratories (NYSE:ABT)? - Yahoo Finance
Empirical Asset Management LLC Has $5.41 Million Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Inspirion Wealth Advisors LLC - MarketBeat
Ritholtz Wealth Management Grows Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Carnegie Investment Counsel Increases Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Cardiac Marker Testing Market May See a Big Move | Abbott Laboratories, Thermo Fisher Scientific - openPR
Abbott Laboratories (ABT) to Release Earnings on Wednesday - MarketBeat
Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch
Abbott pushes toddler milks that can cause health issues: lawsuit - New York Post
Abbott Laboratories (NYSE:ABT) Shares Sold by Gateway Investment Advisers LLC - MarketBeat
StrongBox Wealth LLC Raises Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Brady Family Wealth LLC Sells 2,687 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Baby formula maker sued for deceptively marketing sugar-filled milk - WWJ
St. Louis Financial Planners Asset Management LLC Invests $1.77 Million in Abbott Laboratories (NYSE:ABT) - MarketBeat
3,855 Shares in Abbott Laboratories (NYSE:ABT) Acquired by USA Financial Formulas - MarketBeat
Abbott Labs sued for allegedly misleading parents in toddler milk products - KHOU.com
Sawyer & Company Inc Lowers Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Websterrogers Financial Advisors LLC Takes $259,000 Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Stock Holdings Increased by Sendero Wealth Management LLC - MarketBeat
Abbott Laboratories (NYSE:ABT) Holdings Boosted by Park Avenue Securities LLC - MarketBeat
Biomarker Research Services Market Projected To Witness Substantial Growth, 2025-2032:Abbott Laboratories, - EIN News
Abbott's Toddler Nutrition Drinks Aren't Healthy, Parents Claim - Law360
Abbott closes Cardiomems coverage saga with Medicare win - BioWorld Online
Abbott accused of deceiving parents with potentially harmful formula for toddlers - CBS News
Abbott Laboratories stock underperforms Wednesday when compared to competitors - MarketWatch
Abbott Laboratories Stock (ABT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.43%
0.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):